Company intelligence / Profile preview

Novel Labs

Ownership: Private
Development stage: Other

Overview

Novel Labs is an innovative startup focused on integrating artificial intelligence and advanced hardware into operational infrastructures. Their technologies are tested in energy management and pharmaceutical supply chains, aiming to enhance efficiency, sustainability, transparency, and preparedness for disruptions such as Black Swan events. They do not develop drugs themselves but provide enabling technology to the pharma sector.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Novel Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel Labs.